INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

ACETAdicet Bio, Inc.

CIK 0001720580

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 0
Max Insider Score9
Connections5with evidence

ACET · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
PK
Peng KatieDirector
ACETAdicet Bio, Inc.
Grant or award
A—
4,200 sh
Jun 21, 2026Jun 23, 2026
traded Jun 21, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Peng KatieDirector · Jun 23, 2026
  • ← Insider ofevidence
    Maltzman Julia D.Chief Medical Officer · Mar 27, 2026
  • ← Insider ofevidence
    Healey DonChief Technology Officer · Mar 27, 2026
9
AB
Aftab BlakeChief Scientific Officer
ACETAdicet Bio, Inc.
Grant or award
A
—
55.0K sh
Jun 19, 2026
Jun 23, 2026
traded Jun 19, 2026
+4d
SEC FORM 4

Evidence

9
MD
Maltzman Julia D.Chief Medical Officer
ACETAdicet Bio, Inc.
Grant or award
A—
72.6K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

9
AB
Aftab BlakeChief Scientific Officer
ACETAdicet Bio, Inc.
Grant or award
A—
72.6K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

9
HD
Healey DonChief Technology Officer
ACETAdicet Bio, Inc.
Grant or award
A—
43.4K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

← Insider ofevidence
Aftab Blake
Chief Scientific Officer · Mar 27, 2026